Author Correction: Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors (Investigational New Drugs, (2022), 40, 3, (596-605), 10.1007/s10637-022-01216-8)

Saiama N. Waqar, Clifford Robinson, Anthony J. Olszanski, Alexander Spira, Melissa Hackmaster, Luisa Lucas, Laura Sponton, Hulin Jin, Ursula Hering, Damien Cronier, Marianna Grinberg, Annick Seithel-Keuth, Ivan Diaz-Padilla, Jordan Berlin

Research output: Contribution to journalComment/debate

Abstract

The article Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors was originally published electronically on the publisher’s internet portal on 12 January 2022 without open access. The author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to

Original languageEnglish
Pages (from-to)679
Number of pages1
JournalInvestigational New Drugs
Volume40
Issue number3
DOIs
StatePublished - Jun 2022

Fingerprint

Dive into the research topics of 'Author Correction: Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors (Investigational New Drugs, (2022), 40, 3, (596-605), 10.1007/s10637-022-01216-8)'. Together they form a unique fingerprint.

Cite this